70 related articles for article (PubMed ID: 17553599)
1. [The spliceosome and its interest for lupus therapy].
Monneaux F; Muller S
Rev Med Interne; 2007 Oct; 28(10):725-8. PubMed ID: 17553599
[TBL] [Abstract][Full Text] [Related]
2. Importance of spliceosomal RNP1 motif for intermolecular T-B cell spreading and tolerance restoration in lupus.
Monneaux F; Parietti V; Briand JP; Muller S
Arthritis Res Ther; 2007; 9(5):R111. PubMed ID: 17963484
[TBL] [Abstract][Full Text] [Related]
3. Murine models of systemic lupus erythematosus: B and T cell responses to spliceosomal ribonucleoproteins in MRL/Fas(lpr) and (NZB x NZW)F(1) lupus mice.
Monneaux F; Dumortier H; Steiner G; Briand JP; Muller S
Int Immunol; 2001 Sep; 13(9):1155-63. PubMed ID: 11526096
[TBL] [Abstract][Full Text] [Related]
4. B and T cell immune response to small nuclear ribonucleoprotein particles in lupus mice: autoreactive CD4(+) T cells recognize a T cell epitope located within the RNP80 motif of the 70K protein.
Monneaux F; Briand JP; Muller S
Eur J Immunol; 2000 Aug; 30(8):2191-200. PubMed ID: 10940910
[TBL] [Abstract][Full Text] [Related]
5. T cell recognition and therapeutic effect of a phosphorylated synthetic peptide of the 70K snRNP protein administered in MR/lpr mice.
Monneaux F; Lozano JM; Patarroyo ME; Briand JP; Muller S
Eur J Immunol; 2003 Feb; 33(2):287-96. PubMed ID: 12548559
[TBL] [Abstract][Full Text] [Related]
6. Pattern of anti-small nuclear ribonucleoprotein antibodies in MRL/Mp-lpr/lpr mice suggests that the intact U1 snRNP particle is their autoimmunogenic target.
Fatenejad S; Brooks W; Schwartz A; Craft J
J Immunol; 1994 Jun; 152(11):5523-31. PubMed ID: 7514640
[TBL] [Abstract][Full Text] [Related]
7. Intramolecular T cell spreading in unprimed MRL/lpr mice: importance of the U1-70k protein sequence 131-151.
Monneaux F; Parietti V; Briand JP; Muller S
Arthritis Rheum; 2004 Oct; 50(10):3232-8. PubMed ID: 15476231
[TBL] [Abstract][Full Text] [Related]
8. Modulation of deregulated chaperone-mediated autophagy by a phosphopeptide.
Macri C; Wang F; Tasset I; Schall N; Page N; Briand JP; Cuervo AM; Muller S
Autophagy; 2015; 11(3):472-86. PubMed ID: 25719862
[TBL] [Abstract][Full Text] [Related]
9. The spliceosomal phosphopeptide P140 controls the lupus disease by interacting with the HSC70 protein and via a mechanism mediated by gammadelta T cells.
Page N; Schall N; Strub JM; Quinternet M; Chaloin O; Décossas M; Cung MT; Van Dorsselaer A; Briand JP; Muller S
PLoS One; 2009; 4(4):e5273. PubMed ID: 19390596
[TBL] [Abstract][Full Text] [Related]
10. B and T cell responses to the spliceosomal heterogeneous nuclear ribonucleoproteins A2 and B1 in normal and lupus mice.
Dumortier H; Monneaux F; Jahn-Schmid B; Briand JP; Skriner K; Cohen PL; Smolen JS; Steiner G; Muller S
J Immunol; 2000 Aug; 165(4):2297-305. PubMed ID: 10925319
[TBL] [Abstract][Full Text] [Related]
11. Anti-nucleosome antibodies and T-cell response in systemic lupus erythematosus.
Fournel S; Muller S
Ann Med Interne (Paris); 2002 Dec; 153(8):513-9. PubMed ID: 12610425
[TBL] [Abstract][Full Text] [Related]
12. Spliceosomal peptide P140 for immunotherapy of systemic lupus erythematosus: results of an early phase II clinical trial.
Muller S; Monneaux F; Schall N; Rashkov RK; Oparanov BA; Wiesel P; Geiger JM; Zimmer R
Arthritis Rheum; 2008 Dec; 58(12):3873-83. PubMed ID: 19035498
[TBL] [Abstract][Full Text] [Related]
13. B cells process and present lupus autoantigens that initiate autoimmune T cell responses.
Mamula MJ; Fatenejad S; Craft J
J Immunol; 1994 Feb; 152(3):1453-61. PubMed ID: 8301145
[TBL] [Abstract][Full Text] [Related]
14. Selective modulation of CD4+ T cells from lupus patients by a promiscuous, protective peptide analog.
Monneaux F; Hoebeke J; Sordet C; Nonn C; Briand JP; Maillère B; Sibillia J; Muller S
J Immunol; 2005 Nov; 175(9):5839-47. PubMed ID: 16237076
[TBL] [Abstract][Full Text] [Related]
15. Identification of T-cell epitopes on U1A protein in MRL/lpr mice: double-negative T cells are the major responsive cells.
Yang MH; Suen JL; Li SL; Chiang BL
Immunology; 2005 Jun; 115(2):279-86. PubMed ID: 15885135
[TBL] [Abstract][Full Text] [Related]
16. HSC70 blockade by the therapeutic peptide P140 affects autophagic processes and endogenous MHCII presentation in murine lupus.
Page N; Gros F; Schall N; Décossas M; Bagnard D; Briand JP; Muller S
Ann Rheum Dis; 2011 May; 70(5):837-43. PubMed ID: 21173017
[TBL] [Abstract][Full Text] [Related]
17. A therapeutic peptide in lupus alters autophagic processes and stability of MHCII molecules in MRL/lpr B cells.
Page N; Gros F; Schall N; Briand JP; Muller S
Autophagy; 2011 May; 7(5):539-40. PubMed ID: 21282971
[TBL] [Abstract][Full Text] [Related]
18. Influence of antigen organization on the development of lupus autoantibodies.
Fatenejad S; Bennett M; Moslehi J; Craft J
Arthritis Rheum; 1998 Apr; 41(4):603-12. PubMed ID: 9550469
[TBL] [Abstract][Full Text] [Related]
19. Vaccination with autoreactive CD4(+)Th1 clones in lupus-prone MRL/Mp-Fas(lpr/lpr) mice.
Fujii T; Okada M; Fujita Y; Sato T; Tanaka M; Usui T; Umehara H; Mimori T
J Autoimmun; 2009 Sep; 33(2):125-34. PubMed ID: 19596182
[TBL] [Abstract][Full Text] [Related]
20. Identification of systemically expanded activated T cell clones in MRL/lpr and NZB/W F1 lupus model mice.
Zhou G; Fujio K; Sadakata A; Okamoto A; Yu R; Yamamoto K
Clin Exp Immunol; 2004 Jun; 136(3):448-55. PubMed ID: 15147346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
